PUBLIC COMPANY
saveSpur Therapeutics Ltd
updated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Gaucher Disease Gene Therapy Trial With FLT201
- phase2Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)
- phase1A Gene Therapy Study in Patients With Gaucher Disease Type 1
- phase2A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190
- phase2Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B
- phase2A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy
- phase2A Fabry Disease Gene Therapy Study
🐶 Hiring Signal
News
- Lilly drops another gene therapy trial from $1B Prevail buyoutEli Lilly has axed another trial of a gene therapy acquired in its $1 billion Prevail Therapeutics buyout, further denting the drugmaker’s chances of delivering a return on its investment.fiercebiotech · 16d ago
comments(0)
5-min edit window · permanent after that